ROELOF RONGEN

Profile

First Name

: ROELOF

Middle Name

:

Last Name

: RONGEN

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

MATINAS BIOPHARMA, INC.

GEORGE BOBOTAS, HERBERT CONRAD, STEFANO FERRARI, JEROME JABBOUR

EXECUTIVE OFFICER, DIRECTOR

MATINAS BIOPHARMA HOLDINGS, INC.

GEORGE BOBOTAS, HERBERT CONRAD, EVELYN D-AN, ERIC ENDE, ABDEL A. FAWZY, STEFANO FERRARI, GARY GAGLIONE, NATASHA GIORDANO, STEPHEN P HARRINGTON, JEROME JABBOUR, DOUGLAS F. KLING, KEITH KUCINSKI, RAPHAEL J. MANNINO, JAMES SCIBETTA, ROBIN SMITH, ADAM STERN, MATTHEW WIKLER

DIRECTOR

ALBERT ARGO, DAVID BAKER, VIPIN KUMAR CHATURVEDI, WALTER MARC HERTZ, LEANNE KELLY, CAMILLA SIMPSON, CAMILLA V. SIMPSON, DAVID SZEKERES

EXECUTIVE OFFICER, DIRECTOR

ADOLORE BIOTHERAPEUTICS, INC.

LOU ALTIERI, PAUL BARONE, PAUL HENRY BARONE, ROY LEVITT, MARK ROGERS

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2025-09-10

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2024-10-21

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2023-12-15

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2023-04-21

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2017-01-13

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2016-07-29

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2015-03-31

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-07-30

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2012-12-14